Tensha Therapeutics Seals $15M Series A
HealthCare Ventures has poured $15 million into Tensha Therapeutics, a company developing "epigenetic modulators of gene expression," designed to treat cancer and other serious disorders. HealthCare Ventures was the sole investor in the round.
12 September 2011•4 mins read
